Indivior PLC (LON:INDV) had its price target hoisted by stock analysts at Jefferies Group from GBX 370 ($4.62) to GBX 450 ($5.62) in a research report issued to clients and investors on Monday. The brokerage presently has a “buy” rating on the specialty pharmaceutical company’s stock. Jefferies Group’s price objective would indicate a potential upside of 33.45% from the company’s current price.
INDV has been the subject of several other research reports. Stifel Nicolaus lifted their price objective on shares of Indivior PLC from GBX 310 ($3.87) to GBX 350 ($4.37) and gave the stock a “buy” rating in a research note on Monday, July 11th. Numis Securities Ltd assumed coverage on shares of Indivior PLC in a research note on Friday, July 22nd. They issued a “buy” rating and a GBX 340 ($4.25) price objective for the company. Deutsche Bank AG reiterated a “buy” rating and issued a GBX 290 ($3.62) price objective on shares of Indivior PLC in a research note on Monday, August 1st. Finally, Royal Bank Of Canada lifted their price objective on shares of Indivior PLC from GBX 185 ($2.31) to GBX 325 ($4.06) and gave the stock a “sector performer” rating in a research note on Tuesday, August 9th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of GBX 369.29 ($4.61).
Shares of Indivior PLC (LON:INDV) traded up 1.11% during trading on Monday, hitting GBX 337.20. 1,236,848 shares of the stock were exchanged. Indivior PLC has a 52 week low of GBX 126.60 and a 52 week high of GBX 377.00. The firm’s market capitalization is GBX 2.43 billion. The firm has a 50 day moving average price of GBX 330.40 and a 200 day moving average price of GBX 279.42.